CATALYST PHARMACEUTICALS, INC. 8-K

What Happened

• Catalyst Pharmaceuticals, Inc. (CPRX) filed a Current Report on Form 8-K on January 12, 2026, reporting a Regulation FD disclosure. The company attached a corporate presentation as Exhibit 99.1 to the 8-K and incorporated that presentation by reference into the filing.

Key Details

• Filing date: January 12, 2026 (Form 8-K).
• Item reported: 7.01 — Regulation FD Disclosure; the presentation is attached as Exhibit 99.1.
• Exhibit listed under Item 9.01: Exhibit 99.1 (Presentation dated January 12, 2026) and the cover page interactive XBRL file.

Why It Matters

• This 8-K notifies investors that Catalyst has publicly released a presentation under Regulation FD; investors should review Exhibit 99.1 for any new business updates or disclosures the company chose to share. The filing does not report earnings, revenue figures, executive changes, mergers, or other material financial events — it is a disclosure of a presentation rather than a quarterly or transaction filing.